VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | Mutations in ALL and their implications for treatment decisions

Kjeld Schmiegelow, MD, Rigshospitalet University Hospital, Copenhagen, Denmark, emphasizes the importance of evaluating the risk associated with specific cytogenetic aberrations in acute lymphoblastic leukemia (ALL) in the context of different therapies and their impact on these patient groups. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter